Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO

DRUG: Busulfan
DRUG: Fludarabine
DRUG: Campath 1H
DRUG: Cyclophosphamide
DRUG: MESNA

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Stem cell transplant was determined SOC for this disease (study is not relevant)

Conditions

Baylor College of Medicine